Los Angeles Capital Management LLC cut its stake in Welltower Inc. (NYSE:WELL) by 43.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,076 shares of the real estate investment trust’s stock after selling 10,230 shares during the period. Los Angeles Capital Management LLC’s holdings in Welltower were worth $845,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in WELL. Clear Harbor Asset Management LLC bought a new position in shares of Welltower in the third quarter worth about $28,000. CX Institutional raised its stake in shares of Welltower by 121.7% during the fourth quarter. CX Institutional now owns 490 shares of the real estate investment trust’s stock worth $32,000 after buying an additional 269 shares during the last quarter. Fortis Group Advisors LLC bought a new stake in shares of Welltower during the third quarter worth approximately $45,000. Creative Financial Designs Inc. ADV raised its stake in shares of Welltower by 75.2% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 699 shares of the real estate investment trust’s stock worth $45,000 after buying an additional 300 shares during the last quarter. Finally, Freestone Capital Holdings LLC bought a new stake in shares of Welltower during the third quarter worth approximately $49,000. 89.24% of the stock is owned by institutional investors.
WELL has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Welltower from $71.00 to $67.00 and set a “buy” rating for the company in a research note on Tuesday, January 26th. Evercore ISI downgraded shares of Welltower from an “outperform” rating to an “in-line” rating and set a $64.00 price target for the company. in a research note on Friday, November 13th. Berenberg Bank downgraded shares of Welltower from a “buy” rating to a “hold” rating in a research note on Wednesday, December 2nd. Smith Barney Citigroup upped their target price on shares of Welltower from $50.00 to $65.00 in a research note on Tuesday, December 15th. Finally, Bank of America raised shares of Welltower from an “underperform” rating to a “neutral” rating and upped their target price for the company from $60.00 to $67.00 in a research note on Monday, November 30th. Two investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and six have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $60.69.
Welltower (NYSE:WELL) last released its quarterly earnings results on Tuesday, February 9th. The real estate investment trust reported $0.39 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.77 by ($0.38). The company had revenue of $1.12 billion during the quarter, compared to analyst estimates of $1.13 billion. Welltower had a net margin of 26.20% and a return on equity of 8.64%. The firm’s quarterly revenue was down 11.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.55 EPS. Equities analysts anticipate that Welltower Inc. will post 3.43 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 26th. Investors of record on Monday, February 22nd will be issued a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a yield of 3.49%. The ex-dividend date of this dividend is Friday, February 19th. Welltower’s payout ratio is 58.65%.
Welltower Company Profile
Welltower Inc (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.